ICLR Company Profile and Key Details

Q: Who are the executives of ICLR?

Mr. Brendan BrennanChief Financial OfficerMr. Simon HolmesPres of Corporation Investments & PartnershipsMs. Niamh MurphyDirector of Corporation CommunicationsJonathan CurtainSenior Vice President of Corporation & Commercial Fin.Mr. Diarmaid CunninghamChief Admin. Officer, Gen. Counsel & Company Sec.Ms. Dana Lynn Poff Snr.Executive Vice President of Program ManagementDr. Steven A. Cutler MBA, Ph.D.Chief Executive Officer & DirectorDr. Gary CurtisSenior Vice President of Global Clinical PharmacologyMr. Joe CroninChief HR OfficerMr. Thomas N. O'LearyChief Information Officer

NASDAQ : ICLR

ICON Public

$113.06

2.69+2.44%

At Close 4:00 PM

64.78

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ICON Public Limited Company (ICLR) stock surged +3.04%, trading at $116.50 on NASDAQ, up from the previous close of $113.06. The stock opened at $113.31, fluctuating between $112.53 and $116.65 in the recent session.

Stock Snapshot

113.06

Prev. Close

8.9B

Market Cap

112.53

Day Low

15.7

P/E Ratio

7.42

EPS (TTM)

12.27

Cash Flow per Share

113.31

Open

76.36M

Number of Shares

116.65

Day High

98.74%

Free Float in %

112.15

Book Value

1.36M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 14, 2026	110.54	114.29	110.25	113.06	899.38K
Apr 13, 2026	106.22	111.09	105.05	110.37	950.96K
Apr 10, 2026	107.76	107.76	104.07	106.81	669.62K
Apr 09, 2026	105.12	106.83	102.53	106.70	692.96K
Apr 08, 2026	111.90	113.12	106.15	106.54	784.73K
Apr 07, 2026	109.62	110.74	106.42	107.16	535.65K
Apr 06, 2026	113.50	114.06	108.15	109.62	633.33K
Apr 02, 2026	110.06	115.63	108.58	114.19	660.59K
Apr 01, 2026	110.83	112.94	110.33	111.42	798.21K
Mar 31, 2026	105.10	112.01	103.19	110.66	1.19M
Mar 30, 2026	103.07	106.90	102.30	105.10	1.09M
Mar 27, 2026	102.70	103.97	100.95	102.08	1.05M
Mar 25, 2026	102.40	104.27	97.11	99.99	557.66K
Mar 24, 2026	99.88	103.92	98.60	101.28	750.42K
Mar 23, 2026	101.05	103.42	99.88	100.35	802.57K
Mar 20, 2026	98.18	100.70	97.21	99.70	1.37M
Mar 19, 2026	96.01	98.77	95.75	98.05	669.02K
Mar 18, 2026	98.30	99.73	96.50	97.14	1.14M
Mar 17, 2026	98.99	102.34	98.01	100.49	828.16K
Mar 16, 2026	99.94	100.68	96.00	97.61	1.05M

Contact Details

Dublin, 18

Ireland

https://www.iconplc.com 353 129 12000

About Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Stock Peers

IDXX

10.04998+1.75%

IDEXX Laboratories, Inc.$584.05 MEDP

18.77+3.74%

Medpace Holdings, Inc.$520.00 NTRA

12.74+6.31%

Natera, Inc.$214.64 ILMN

3.36+2.65%

Illumina, Inc.$130.32 EXAS

Exact Sciences Corporation$104.91 GH

4.19+5.10%

Guardant Health, Inc.$86.40 BLLN

4.09+5.20%

BillionToOne, Inc.$82.79 RDNT

1.53+2.72%

RadNet, Inc.$57.76 TWST

7.03+13.95%

Twist Bioscience Corporation$57.41 GRAL

2.45+5.10%

GRAIL, Inc.$50.49

Company Overview

ICON Public Limited Company (NASDAQ:ICLR) closed at $116.50 USD, gaining $3.44 (3.04%) from the previous close of $113.06. The stock is currently mid-range between its 52-week high and low $66.57 and $211.00. With a market capitalization of about $8.90 billion, ICON Public Limited Company is classified as a mid-cap and shows market-like volatility (beta ~1.28). Key stats such as the average daily volume over the past year has been around 1.81 million shares, in line with its 52-week average. Headquartered in Dublin, None, ICON Public Limited Company operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Barry Balfe, the company employs approximately 41,250 people and listed since May 15, 1998. ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Technical Performance

ICLR has shown mixed momentum, losing -1.99% over the past week and -4.59% over the past quarter, though year-to-date performance is down -3.1%. Short-term trend indicators are bullishly aligned (SMA20 -17.61%, SMA50 -34.66%, SMA200 -35.2%). The stock’s 14-day RSI is 34.59 (weak momentum), while the ATR of 9.95 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -49.7% below its high and over 59.43% above its low. Average 10-day trading volume of 738.09 thousand shares is below the 3-month average of 1.84 million, indicating normal recent market interest.

Valuation Metrics

ICON Public Limited Company trades at a P/E ratio of 14.57, slightly below the S&P 500 average, with a price-to-sales ratio of 1.06 and a price-to-book ratio of 0.94 suggesting the stock is closer to book value. The P/FCF stands at 8.65, also below market averages.

Dividend & Fair Value

ICON Public Limited Company last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $177.63. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

ICON Public Limited Company generated EPS of $7.40 over the past year. Five-year average earnings growth is 6.54%. Wall Street analysts project EPS growth of -1.09% annually over the next five years. The latest quarter delivered EPS of $3.31. The next quarter is forecast at $3.23. Next year's EPS is expected at $16.56. Analyst sentiment is neutral. Analyst rating data shows there are 6 Strong Buy ratings, 5 Buy ratings, 12 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $240.00 to $130.00. The high target offers 112.28% upside. The low target suggests 14.98% downside. The mean target is $198.78. This offers 75.82% upside. ICON Public Limited Company earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 22, 2025, missed forecasts by 0.91%. The prior quarter beat by 2.19%. Over the last six quarters, Apple has recorded several small beats. These include 1.63% in July 24, 2024.

Shareholding & Insider Activity

ICON Public Limited Company has 77.77 million shares outstanding. The public float is 76.80 million shares, elevated short interest at 2.71% of float. This equals 2.09 million shares. The short ratio is 1.26 days. Institutional investors hold 103.4% of the float. Insiders own 0.65%.

Financial & Profitability Overview

Over the trailing twelve months, ICON Public generated $8.12B in revenue, or $98.17 per share. Gross margin was 22.34%, operating margin 13.04%, and net profit margin 7.54%. Returns are modest, with ROA at 3.60% and ROE at 6.63%.
On valuation metrics, ICON Public trades at a P/E of 14.57, P/S of 1.06 and P/B of 0.94. The current ratio is 1.06 and quick ratio is 1.06. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 119.11 days. Debt-to-equity is 0.38, supported by a cash flow-to-debt ratio of 0.33.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, ICON Public posted revenue of $8.12B, down slightly from $7.74B in the prior quarter. Gross profit was $1.81B (margin 22.34%). Operating income was $1.06B (margin 13.0%). Net income was$612.34M (EPS $7.46).
The company ended the quarter with $380.06M in cash and short-term investments, a total debt of $3.94B, and net debt of $3.56B. Total assets were $16.99B, with equity of $9.24B. Financials further reflected stability, with operating cash flow of $1.16B, free cash flow of $1.02B, and capital expenditures of - $140.69M.

Price Forecast & Outlook

Our AI price prediction model suggests that ICON Public Limited Company stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.6%, with price expected at $116.00 by April 28, 2026, within a range of $111.49 to $120.75 3-Month Outlook: Projected rise of 24.36%, reaching $140.60 by July 13, 2026, with a range of $125.71 to $150.79. 1-Year Outlook: Projected loss of -36.72%, with price at $71.55 by April 14, 2027, within a range of $52.69 to $91.31.

Key Takeaways

ICON Public Limited Company (NASDAQ:ICLR) shares are flat -3.1% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows ICON Public Limited Company trading at a premium to the broader market with a P/E of 14.57. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $253.73, suggesting 124.42% upside. Our AI forecast model points to short-term strength (2.6% over two weeks), a medium-term rise (24.36% over three months), and a longer-term loss (-36.72% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current ICON Public Limited Company (ICLR) stock price?

ICON Public Limited Company (NASDAQ: ICLR) stock price is $116.50 in the last trading session. During the trading session, ICLR stock reached the peak price of $116.65 while $112.53 was the lowest point it dropped to. The percentage change in ICLR stock occurred in the recent session was 3.04% while the dollar amount for the price change in ICLR stock was $3.44.

ICLR's industry and sector of operation?

The NASDAQ listed ICLR is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. ICON Public Limited Company designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ICLR?

Mr. Brendan Brennan
Chief Financial Officer
Mr. Simon Holmes
Pres of Corporation Investments & Partnerships
Ms. Niamh Murphy
Director of Corporation Communications
Jonathan Curtain
Senior Vice President of Corporation & Commercial Fin.
Mr. Diarmaid Cunningham
Chief Admin. Officer, Gen. Counsel & Company Sec.
Ms. Dana Lynn Poff Snr.
Executive Vice President of Program Management
Dr. Steven A. Cutler MBA, Ph.D.
Chief Executive Officer & Director
Dr. Gary Curtis
Senior Vice President of Global Clinical Pharmacology
Mr. Joe Cronin
Chief HR Officer
Mr. Thomas N. O'Leary
Chief Information Officer

How ICLR did perform over past 52-week?

ICLR's closing price is 69.84% higher than its 52-week low of $66.57 where as its distance from 52-week high of $211.00 is -46.42%.

How many employees does ICLR have?

Number of ICLR employees currently stands at 41,250.

Link for ICLR official website?

Official Website of ICLR is: https://www.iconplc.com

How do I contact ICLR?

ICLR could be contacted at phone 353 129 12000 and can also be accessed through its website. ICLR operates from South County Business Park, Dublin, 18, Ireland.

How many shares of ICLR are traded daily?

ICLR stock volume for the day was 1.36M shares. The average number of ICLR shares traded daily for last 3 months was 1.81M.

What is the market cap of ICLR currently?

The market value of ICLR currently stands at $8.90B with its latest stock price at $116.50 and 76.36M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	41250
Beta	1.28
Sales or Revenue	$8.12B
5Y Sales Change%	1.062%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Diagnostics & Research

ICLR Company Profile and Key Details

ICON Public

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook